Likewise, there was no evidence of a difference between groups when GDM was used as a three-category variable encompassing use of insulin; adjusted OR for antenatal CMD in GDM treated with insulin was 0.93 (95% CI 0.70,1.23) and without insulin was 0.88 (0.64,1.21). This evidence concerns the gene INS and gestational diabetes.